CoChat

Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis

Pan, Xin‐Hui, Tan, Bryan, Chin, Yip Han, Lee, Ethan Cheng Zhe, Kong, Gwyneth, Chong, Bryan, Kueh, Martin, Khoo, Chin Meng, Mehta, Anurag, Majety, Priyanka, Grandhi, Gowtham R., Dimitriadis, Georgios K., Foo, Roger, Chew, Nicholas W. S., Le Roux, Carel W., Mamas, Mamas A., Chan, Mark Y. · 2024 · Obesity
Cited by 71

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Objective: This network meta‐analysis evaluates the efficacy and safety of tirzepatide compared to glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and other weight loss drugs in the treatment of overweight and obesity. Methods: MEDLINE, Embase, and Cochrane CENTRAL were searched for randomized controlled trials on tirzepatide, GLP‐1 RA, and weight loss drugs approved by the US Food and Drug Administration. A network meta‐analysis was performed, drawing direct and indirect comparisons between treatment groups. Network diagrams and surface under the cumulative ranking curve analysis were performed for primary (≥5%, ≥10%, ≥15%, absolute weight loss) and secondary outcomes and adverse effects. Results: Thirty‐one randomized controlled trials, involving more than 35,000 patients, were included in this study. Tirzepatide 15 mg ranked in the top three across weight‐related parameters, glycemic profile (glycated hemoglobin), lipid parameters (total cholesterol, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides), and blood pressure. Tirzepatide 15 mg had the highest efficacy compared with placebo for achieving ≥15% weight loss (risk ratio 10.24, 95% CI: 6.42–16.34). As compared to placebo, tirzepatide and GLP‐1 RA across all doses had significant increases in gastrointestinal adverse effects. Conclusions: The superiority of tirzepatide and GLP‐1 RA in inducing weight loss and their ability to target multiple metabolic parameters render them promising candidates in the treatment of patients with overweight and obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/oby.24002

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 35

  1. 10.1016/j.metabol.2018.09.005 · DOI · Paper page
  2. 10.1093/ajcn/72.3.694 · DOI · Paper page
  3. 10.1136/bmjgh‐2022‐009773 · DOI · Paper page
  4. World Obesity, 2023, World Obesity Atlas 2023
  5. Lobstein T, World Obesity Atlas 2022
  6. 10.1016/j.eprac.2022.10.006 · DOI
  7. 10.1038/s41430‐020‐0610‐y · DOI
  8. 10.1046/j.1365‐2125.2001.01294.x · DOI
  9. 10.1900/RDS.2014.11.202 · doi:10.1900/rds.2014.11.202
  10. 10.7570/jomes22012 · DOI
  11. 10.1371/journal.pone.0285197 · DOI · Paper page
  12. 10.1016/S0140‐6736(03)15268‐3 · DOI · Paper page
  13. 10.1002/jrsm.1058 · DOI · Paper page
  14. 10.1002/sim.6236 · DOI · Paper page
  15. 10.1002/jrsm.1143 · DOI
  16. 10.1002/sim.8158 · DOI · Paper page
  17. 10.18549/PharmPract.2017.01.943 · DOI · Paper page
  18. 10.3945/ajcn.111.024927 · DOI · Paper page
  19. 10.1016/S0140‐6736(10)60888‐4 · DOI · Paper page
  20. 10.1038/oby.2009.155 · DOI · Paper page
  21. 10.1016/S0140‐6736(18)31773‐2 · DOI · Paper page
  22. 10.2337/dc13‐0354 · DOI
  23. 10.1001/jama.2021.3224 · DOI · Paper page
  24. 10.1016/S0140‐6736(23)01200‐X · DOI · Paper page
  25. 10.2165/00002018‐200831010‐00005 · DOI · Paper page
  26. 10.3390/ph14100991 · DOI · Paper page
  27. 10.1161/CIRCRESAHA.116.307591 · DOI · Paper page
  28. 10.3389/fphar.2022.998816 · DOI
  29. 10.3389/fcvm.2021.768119 · DOI · Paper page
  30. 10.1016/S0140‐6736(15)00803‐X · DOI · Paper page
  31. 10.1016/S2213‐8587(22)00070‐5 · DOI · Paper page
  32. 10.23876/j.krcp.22.001 · DOI
  33. 10.1111/j.1755‐5949.2010.00172.x · DOI · Paper page
  34. 10.5414/CP202135 · DOI
  35. 10.1111/j.1463‐1326.2010.01242.x · DOI · Paper page

Cited by

Metadata

Authors
Pan, X., Tan, B., Chin, Y. H., Lee, E. C. Z., Kong, G., Chong, B., Kueh, M., Khoo, C. M., Mehta, A., Majety, P., Grandhi, G. R., Dimitriadis, G. K., Foo, R., Chew, N. W. S., Le Roux, C. W., Mamas, M. A., & Chan, M. Y.
Venue
Obesity
Publisher
Wiley
Published
2024-02-27
Volume
32
Issue
5
Pages
840-856
ISSN
  • 1930-7381 (ISSN-L)
  • 1930-739X
OpenAlex
W4392772523
Cited by
71
References
59
FWCI
16.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.